Navigation Links
Brand Name Drug Prices Zoom

A report has found that prices of 200 brand name drugs which are taken regularly by older Americans have risen by 6.3% during the 12 month period ending // mid June 2006, against an inflation rate of 3.8%. The survey was conducted by AARP and reported in their Rx Watchdog Report released on Tuesday. It is also reported that the prices of 75 commonly used generic drugs remain the same.

Heading the list of drugs with highest price rise is Aventis' Ambien 5mg with a hike of 13.3%.It is followed by Boehringer Ingelheim's Combivent (12%), Pfizer's Atrovent (12%), Ambien 10mg (9.9%) and Glaxo Smith Kline's Wellbutin (9.4%).

The biggest average six month price rise has been reported in Aventis, up by 7.7% and the lowest in Monarch and Takeda (0%) and Lilly (2.5%).

The report author Susan Raetzman, assosiate director of AARP's Public Policy Institute said that though the rate of price increase is the same as in recent years, it means an increase of over $70 annually, for a drug which is taken regularly. Considering an average annual cost of $300 on drugs for older people, this is quite steep.

Raetzman said that this would also affect people on Medicare Plan D as the cost increases get passed on to its members.

To help contain the drug price hikes AARP is supporting a bill in Congress, which will permit the import of drugs from Canada and other western countries.

David Sloane, AARP's senior managing director of government relations said in a prepared statement that for the first time a bill of this nature has received widespread support .It would allow safe and legal import of drugs.

The executive director, Sharon Treat of the National Legislative Association on Prescription Drug Prices, a nonpartisan, nonprofit group founded by state legislators to make prescription drugs more affordable and accessible to Americans, said that the price increases are unjustified.

She felt that the people and the government were being ripped off and added that the Medicare Plan D seems to have spurred on the price increase. Under this plan the federal government cannot negotiate the prices of the drugs, which has resulted in a situation where reduction in the prices is not a priority.
'"/>




Related medicine news :

1. Variations In ingredients From Brand to Brand
2. Drinking Brandy Is Good For Health
3. Marketing of Low Tar Cigarette Brand by BAT Unethical
4. New Research Reveals How We Process Brands And Products
5. Big Brands Ensure Lasting Influences In Dietary Choices.
6. Brain Responds Better to Name Brands
7. Salmonella Contamination Suspected In A Brand Of Fresh Spinach
8. Some Brands of Ready Meals Recalled After Glass Scare
9. Two Brands of Pesto Recalled in Quebec, Ontario
10. Drug Companies May Be Penalize For Overcharging NHS Tax Payers Money on Branded Drugs
11. Ark Land Brand Bottled Water Faces a Bottleneck
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a ... new strategies to reduce waste, and support renewable energy. They believe this is a ... nature to find solutions for health issues, and maintain that destroying the environment in ...
(Date:4/24/2017)... ... April 24, 2017 , ... The California Dental Association Foundation’s two-day volunteer dental ... 1,961 people during the April 22-23 event at the San Mateo Event Center. ... barriers to care, CDA Cares educates the public and policymakers about the importance of ...
(Date:4/24/2017)... McLean, Virginia (PRWEB) , ... April 24, 2017 ... ... have announced that they are seeking public support to bring their novel lifesaving ... in appearance, wearable device packed with medical-grade sensors, specially designed to read a ...
(Date:4/24/2017)... ... April 24, 2017 , ... In 2017, ... diagnosed globally; approximately 25,000 of them will be malignant.(1) As research into precision ... type of healthcare model in the diagnosis and treatment of brain tumors. Healthcare ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) ... Jim Walter Blvd, for an educational and exciting 2-day program. , An attendee ... hearing this before they approach patients” about the course entitled Ain't Misbehavin': Decreasing and ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... Gynecology markets with innovative and proprietary products, will release ... 2017 after the market close on Tuesday, May 2, ... conference call and webcast to discuss its financial results ... 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
(Date:4/18/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 6.35% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and ... today announced the signing of a three-year exclusive ... will deploy a dedicated sales team to introduce ... U.S., primarily focused in 13 states in the ...
Breaking Medicine Technology: